Zejing Pharmaceutical announced that the company's self-developed injectable recombinant human thyroid-stimulating hormone (rhTSH) recently submitted a biological product marketing license application (BLA) to the State Drug Administration, which is currently awaiting formal acceptance.
泽璟制药：递交注射用重组人促甲状腺激素生物制品上市许可申请
Zejing Pharmaceutical: Submits marketing license application for injectable recombinant human thyroid-stimulating hormone biological products
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated